-
公开(公告)号:US07435553B2
公开(公告)日:2008-10-14
申请号:US11434403
申请日:2006-05-15
申请人: James P Fandl , Neil Stahl , Gang Chen , George D. Yancopoulos
发明人: James P Fandl , Neil Stahl , Gang Chen , George D. Yancopoulos
CPC分类号: C40B30/04 , A01K2217/05 , A01K2267/01 , C07K14/315 , C07K14/52 , C07K16/2863 , C07K2317/77 , C07K2319/00 , C12N15/1051 , G01N33/56966 , G01N33/6845 , G01N2500/10
摘要: A method of detecting and isolating cells that produce any secreted protein of interest (POI), comprising: a) constructing a cell line transiently or stably expressing a cell surface capture molecule, which binds the POI, by transfecting the cell line with a nucleic acid that encodes such cell surface capture molecule; b) transfecting said cell simultaneously or subsequently with a second nucleic acid that encodes a POI wherein such POI is secreted; c) detecting the surface-displayed POI by contacting the cells with a detection molecule, which binds the POI; and d) isolating cells based on the detection molecule.
摘要翻译: 一种检测和分离产生任何分泌的感兴趣蛋白质(POI)的细胞的方法,包括:a)通过用核酸转染细胞系来构建瞬时或稳定表达结合POI的细胞表面捕获分子的细胞系 编码这种细胞表面捕获分子; b)同时或随后用编码POI的第二核酸同时转染所述细胞,其中所述POI被分泌; c)通过使细胞与结合POI的检测分子接触来检测表面显示的POI; 和d)基于检测分子分离细胞。
-
公开(公告)号:US06919183B2
公开(公告)日:2005-07-19
申请号:US10050279
申请日:2002-01-16
申请人: James P. Fandl , Neil Stahl , Gang Chen , George D. Yancopoulos
发明人: James P. Fandl , Neil Stahl , Gang Chen , George D. Yancopoulos
IPC分类号: A01K67/027 , C07K14/315 , C07K14/52 , C07K16/28 , C12N5/10 , C12N15/09 , C40B30/04 , G01N33/569 , G01N33/68 , G01N33/53 , C12N21/02 , C12N21/08
CPC分类号: C40B30/04 , A01K2217/05 , A01K2267/01 , C07K14/315 , C07K14/52 , C07K16/2863 , C07K2317/77 , C07K2319/00 , C12N15/1051 , G01N33/56966 , G01N33/6845 , G01N2500/10
摘要: A method for identifying and isolating cells which produce secreted proteins. This method is based upon a specific characteristic or the expression level of the secreted protein by transiently capturing the secreted protein on the surface of an individual cell, allowing selection of rare cell clones from a heterogeneous population. Also provided is the use of this method to generate cells which produce a desired level of secreted protein or secreted protein of a particular characteristic(s), and organisms which possess such cells. In particular, the method allows rapid isolation of high expression recombinant antibody-producing cell lines, or may be applied directly to rapid isolation of specific hybridomas, or to the isolation of antibody-producing transgenic animals. This method is applicable for any cell which secretes protein.
摘要翻译: 用于鉴定和分离产生分泌蛋白的细胞的方法。 该方法基于通过瞬时捕获单个细胞表面上的分泌蛋白质的分泌蛋白质的特定特征或表达水平,允许从异质群体中选择稀有细胞克隆。 还提供了这种方法用于产生产生具有特定特征的所需水平的分泌蛋白质或分泌蛋白质的细胞以及具有这种细胞的生物体的用途。 特别地,该方法允许高表达重组抗体产生细胞系的快速分离,或者可以直接应用于快速分离特异性杂交瘤,或分离产生抗体的转基因动物。 该方法适用于分泌蛋白质的任何细胞。
-
公开(公告)号:US20090137416A1
公开(公告)日:2009-05-28
申请号:US12240541
申请日:2008-09-29
申请人: James P. Fandl , Gang Chen , Neil Stahl , George D. Yancopoulos
发明人: James P. Fandl , Gang Chen , Neil Stahl , George D. Yancopoulos
CPC分类号: G01N33/6854 , C12N15/65 , G01N33/566 , G01N33/56966 , G01N2333/7051
摘要: A method of detecting and isolating cells that produce a secreted protein of interest (POI) that has a T cell receptor variable domain, comprising: a) constructing a cell line transiently or stably expressing a cell surface capture molecule, which binds the POI, by transfecting the cell line with a nucleic acid that encodes such cell surface capture molecule; b) transfecting said cell simultaneously or subsequently with a second nucleic acid that encodes a POI wherein such POI is secreted; c) detecting the surface-displayed POI by contacting the cells with a detection molecule, which binds the POI; and d) isolating cells based on the detection molecule.
摘要翻译: 一种检测和分离产生具有T细胞受体可变区的目标分泌蛋白质(POI)的细胞的方法,包括:a)通过以下步骤构建细胞系:瞬时或稳定表达结合POI的细胞表面捕获分子,通过 用编码这种细胞表面捕获分子的核酸转染细胞系; b)同时或随后用编码POI的第二核酸同时转染所述细胞,其中所述POI被分泌; c)通过使细胞与结合POI的检测分子接触来检测表面显示的POI; 和d)基于检测分子分离细胞。
-
公开(公告)号:US20080220004A1
公开(公告)日:2008-09-11
申请号:US11998709
申请日:2007-11-30
申请人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
发明人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
IPC分类号: A61K39/395 , A61K38/02
CPC分类号: C07K14/71 , A61K38/00 , A61K38/179 , C07K14/47 , C07K2319/00 , C07K2319/30
摘要: Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
摘要翻译: 公开了具有改善的药物动力学和改善的组织穿透的修饰的嵌合多肽,其可用于治疗眼睛疾病,包括年龄相关性黄斑变性和糖尿病性视网膜病变。
-
公开(公告)号:US07306799B2
公开(公告)日:2007-12-11
申请号:US11089803
申请日:2005-03-25
申请人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
发明人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
CPC分类号: C07K14/71 , A61K38/00 , A61K38/179 , C07K14/47 , C07K2319/00 , C07K2319/30
摘要: Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
摘要翻译: 公开了具有改善的药物动力学和改善的组织穿透的修饰的嵌合多肽,其可用于治疗眼睛疾病,包括年龄相关性黄斑变性和糖尿病性视网膜病变。
-
公开(公告)号:US07521049B2
公开(公告)日:2009-04-21
申请号:US11998709
申请日:2007-11-30
申请人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
发明人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
CPC分类号: C07K14/71 , A61K38/00 , A61K38/179 , C07K14/47 , C07K2319/00 , C07K2319/30
摘要: Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
摘要翻译: 公开了具有改善的药物动力学和改善的组织穿透的修饰的嵌合多肽,其可用于治疗眼睛疾病,包括年龄相关性黄斑变性和糖尿病性视网膜病变。
-
公开(公告)号:US07303747B2
公开(公告)日:2007-12-04
申请号:US11218234
申请日:2005-09-01
申请人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
发明人: Stanley J. Wiegand , Nicholas J. Papadopoulos , George D. Yancopoulos , James P. Fandl , Thomas J. Daly
CPC分类号: C07K14/71 , A61K38/00 , A61K38/179 , C07K14/47 , C07K2319/00 , C07K2319/30
摘要: Modified chimeric polypeptides with improved pharmacokinetics and improved tissue penetration are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
-
公开(公告)号:US07927583B2
公开(公告)日:2011-04-19
申请号:US12177185
申请日:2008-07-22
申请人: Neil Stahl , George D. Yancopoulos
发明人: Neil Stahl , George D. Yancopoulos
CPC分类号: C07H21/04 , A61K38/00 , C07K14/715 , C07K14/7155 , C07K16/244 , C07K2317/622 , C07K2317/73 , C07K2319/00 , C07K2319/02 , C07K2319/30 , C07K2319/32
摘要: The present invention provides a fusion polypeptide capable of binding a cytokine to form a nonfunctional complex. It also provides a nucleic acid sequence encoding the fusion polypeptide and methods of making and uses for the fusion polypeptide.
摘要翻译: 本发明提供能够结合细胞因子以形成非功能性复合物的融合多肽。 它还提供编码融合多肽的核酸序列以及制备和用于融合多肽的方法。
-
公开(公告)号:US07531172B2
公开(公告)日:2009-05-12
申请号:US11502736
申请日:2006-08-11
CPC分类号: A61K38/179
摘要: A method of reducing or preventing hypertension associated with administration of a vascular endothelial growth factor (VEGF) antagonist in a human subjects suffering from a disease or condition treatable with a VEGF antagonist in which is it desirable to reduce or prevent hypertension. The method is particularly useful for treatment of patients unresponsive to treatment with a VEGF inhibitor administered intravenously.
摘要翻译: 在患有可用VEGF拮抗剂治疗的疾病或病症的人类受试者中降低或预防与血管内皮生长因子(VEGF)拮抗剂的给药相关的高血压的方法,其中希望减少或预防高血压。 该方法对于治疗对用静脉内施用的VEGF抑制剂治疗无反应的患者特别有用。
-
公开(公告)号:US07285532B2
公开(公告)日:2007-10-23
申请号:US10735345
申请日:2003-12-12
IPC分类号: A61K38/16
CPC分类号: C07K16/22 , A61K38/00 , A61K39/00 , C07K14/475
摘要: Methods of treating and/or inhibiting a bone morphogenetic protein (BMP)-related disorder or condition by administering a BMP antagonist to a subject suffering from a BMP-related disorder or condition such that the BMP-related disorder or condition is treated. The method is carried out with a human noggin or a human noggin deletion mutant.
摘要翻译: 通过向患有BMP相关病症或病症的受试者施用BMP拮抗剂以治疗和/或抑制骨形态发生蛋白(BMP)相关障碍或病症,使得与BMP相关的病症或病症得到治疗。 该方法用人noggin或人noggin缺失突变体进行。
-
-
-
-
-
-
-
-
-